Of interest is the recent finding of a role for the transcription factor Nrf-1, a central player in controlling expression of antioxidant genes through binding to ARE sequences, in NASH and hepatic cancer development [47]. This evidence concerns the gene NRF1 and metabolic dysfunction-associated steatohepatitis.